Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT01588093
Eligibility Criteria:
Inclusion Criteria:
1. Type 1 diabetes duration at least two years and assumed C-peptide negativity
2. Chronological age from 18 to 25 years
3. Tanner stage \> 4 (Girls: Tanner B4 or more, Boys: Testis \> 15 ml)
4. Levemir or Lantus as basal analogue or CSII
5. IGF-1 \< -1.0 SDS and HbA1C \< 73 mmol/mol with screening or within past three months
6. Written informed consent
Exclusion Criteria:
1\. Development of hypoglycemia that can not be controlled with increased glucose infusion-rate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
23 Years
Study:
NCT01588093
Study Brief:
Protocol Section:
NCT01588093